NCT02925793View on ClinicalTrials.gov

Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)

PHASE2CompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Atopic Dermatitis
Interventions
DRUG

DS107

OTHER

Vehicle cream

Trial Locations (3)

7700

DS Biopharma Site, Cape Town

08520

DS Biopharma Site, East Windsor

L3P 1X2

DS Biopharma Site, Markham

Sponsors

Lead Sponsor

DS Biopharma
All Listed Sponsors
lead

DS Biopharma

INDUSTRY

NCT02925793 - Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD) | Biotech Hunter | Biotech Hunter